ArticleInternational journal of molecular sciences2021

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia.

Naja Nyffenegger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.